Company profile for Merdury Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in July 2019, Merdury Pharmaceutical focuses on the development of drugs for unmet medical needs. StackDose™, a new drug development platform, based on a 3D powder printing technology and process, and a unique drug binding formula, Merdury develops new tablet dosage forms with controlled time dissolution and precise site absorption, and improves the bioavailability of active pharmaceutical ingredients (APIs) to optim...
Founded in July 2019, Merdury Pharmaceutical focuses on the development of drugs for unmet medical needs. StackDose™, a new drug development platform, based on a 3D powder printing technology and process, and a unique drug binding formula, Merdury develops new tablet dosage forms with controlled time dissolution and precise site absorption, and improves the bioavailability of active pharmaceutical ingredients (APIs) to optimize their effects, thereby reducing the dosage of drugs used and thereby reducing side effects.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Taiwan
Address
Address
15th Floor, No. 653, Bannan Road, Zhonghe District, New Taipei City
Telephone
Telephone
886-2-8221-2020
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospectrumasia.com/news/25/24625/taiwan-advances-innovative-drug-delivery-technology-for-diabetes-treatment.html

BIOSPECTRUM ASIA
25 Jul 2024

https://www.prnewswire.com/news-releases/merdury-signs-mou-with-health2sync-to-conduct-trial-of-merdurys-stackdose-technology-intended-for-usage-in-glp-1-semaglutide-medication-302205498.html

PR NEWSWIRE
25 Jul 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty